AmpG permease is implicated both in beta-lactamase induction and peptidoglycan recycling in enterobacterial isolates. Here, physiological studies using molecular genetics show that deletion of AmpG permease dramatically increases beta-lactam susceptibility even in the presence of AmpC, TEM-1 and OXA beta-lactamases. Also, there is an appreciable decrease in the biofilm-forming ability of strains lacking this protein. Expression of this permease in excess probably compromises the integrity of the bacterial cells, leading to cell lysis. Based on these results, we propose that AmpG permease may be used as a potential antibiotic target and its suppression could efficiently inhibit both beta-lactamase induction and biofilm formation.
INTRODUCTION
Antibiotic resistance in enterobacterial nosocomial pathogens is on the rise, and Escherichia coli is one of them. This opportunistic pathogen is increasingly becoming resistant to beta-lactams due to the production of various types of beta-lactamases (Bush 2010) . The ampG gene encodes a transmembrane protein that acts as a permease in many gram-negative bacteria including Pseudomonas aeruginosa, Vibrio cholera, Acinetobacter baumannii and E. coli (Li et al. 2016) . AmpG permease transports peptidoglycan (PG) fragments like 1, 6-GlcNAc-anhydro-MurNAc and 1, 6-GlcNAc-anhydro-MurNAc peptides, usually required for PG recycling. However, if there is an increase in the concentration of these signaling molecules, it induces AmpC expression. Therefore, AmpG permease is a participant in both the PG recycling pathway and the beta-lactamase induction pathway (Chahboune et al. 2005 ).
The beta-lactam antibiotics inhibit PG cross-link formation by blocking penicillin-binding proteins (PBPs) and their attack generates numerous PG fragments, much more than that produced during PG recycling. The AmpG permease internalizes these fragments leading to their accumulation in the cytoplasm. Such PG fragments act as a signal to trigger beta-lactamase production for the hydrolysis of beta-lactams (Dietz, Pfiefle and Wiedemann 1997) . Breakdown of the PG layer compromises the structural integrity of the cell and it is imperative that interference with PG recycling would have subsequent implications in its biofilm-forming ability. Biofilms are consortia of microorganisms held together in an extracellular polymeric matrix with cells in different stages of growth and metabolism (Acker, Dijck and Coenye 2014) . The biofilm mode of growth imparts characteristics to the bacteria that are very different from their planktonic forms. The most pronounced is the exorbitant increase in antimicrobial resistance conferred by biofilms that may range from 10 to 1000 times greater than the planktonic cells (Jefferson 2004) .
Little is known about the appearance of simultaneous resistance that is imparted by biofilms and beta-lactamases together (Bagge et al. 2004; Gallant et al. 2005) . The role of AmpG only with respect to AmpC beta-lactamase has been studied so far. Also, the effect of AmpG on biofilm formation remains to be highlighted. To elucidate any possible dynamic relation between biofilm formation and beta-lactamase induction, we aim to uncover the role of AmpG permease in both serine beta-lactamase induction (classes A, C, and D) and biofilm-forming ability of E. coli both in absence and presence of serine beta-lactamases.
MATERIALS AND METHODS

Strains, plasmids and chemicals
Escherichia coli (CGSC-BW25113) was used as the host strain for genetic modifications (Baba et al. 2006) . The strategy followed here was devised by Datsenko and Wanner (2000) . The strain targeted for gene deletion was transformed with the temperaturesensitive plasmid pKD46 (marker: ampicillin 100 μg/mL; growth temperature: 30
• C) that carries the recombinase gene induced by arabinose. The recombinase was induced with 0.2% arabinose, and competent cells were prepared after recombinase expression. The kanamycin cassette (kan r ) was amplified along with FRT (flippase recognition target) sites on either side such that the amplicon is flanked on both sides by portions of sequences adjacent to the gene to be deleted. The primers used for amplification were FP 5 -GCGTTAATTTCTGCCCTCTG -3 and RP 5 -CGGCGAGTGATTACTACAGC -3 . The PCR amplicons were electroporated into the recombinase expressing cells and transformants were screened against kanamycin (25 mg/L) on LB agar plates. The ampG deletion was verified by PCR using both cloning and deletion primers. On confirmation of deletion, stock was prepared before proceeding for curing kanamycin cassette linked to FRT. The vectors pBAD 18Cam and pBAD 18Kan, under the control of the arabinose promoter, were used for cloning and subsequent expression. The recombinant plasmids created are listed in Table S1 (Supporting Information). Unless otherwise specified, all bacteria were grown and maintained in Luria Bertani broth and incubated at 37 • C. All related enzymes and antibiotics were procured from New England Biolabs (Beverly, MA, USA) and Sigma Chemical Company (St. Louis, MO, USA), respectively. Nitrocefin was acquired from Calbiochem (Merck, Germany).
Antibiotic sensitivity assay
The antibiotic susceptibilities (MIC values) of isolates were determined by the microbroth dilution method and the results interpreted as per CLSI guidelines (Wayne 2007) . The antibiotics used include ampicillin, amoxicillin, penicillin G, cefalothin, cloxacillin, cefoxitin and oxacillin. The antibiotic concentrations used were varied from 0.5 to 0.0005 mg/L. Each well of the 96-well microtiter plate was inoculated with 10 5 cells. After incubation at 37
• C for 18 h, the growth of the culture was measured at A 600nm using a Multiskan Spectrum Spectrophotometer (MSS-model 1500; Thermo Scientific, Nyon, Switzerland). The MIC values for each antibiotic were determined by comparing the cell densities with control wells (without antibiotic). Experiments were carried out in triplicate and repeated at least six times for reproducibility (Mallik et al. 2013) .
Nitrocefin hydrolysis assay
The beta-lactamases were detected by checking the hydrolysis of the chromogenic cephalosporin-nitrocefin, using the cell lysates as the sources of beta-lactamases (Ghosh, Kar and Kundu 1999) . Upon hydrolysis, nitrocefin changes from yellow to red and the extent of hydrolysis was measured using MSS at A 490nm .
Biofilm formation assay
The extent of biofilm formation was determined by the standard crystal violet (CV) assay (Kumar et al. 2012) . Briefly, biofilms were formed in 1 mL of LB broth in 24-well plates. Each well was loaded with 10 5 cells (from fresh cultures) and the plates were incubated for 24 h at 37
• C. The planktonic cells were gently washed out and the biofilms formed in the wells were stained with 0.1% CV for 15 min. Excess stain was removed and the bound CV on the biofilms was solubilized in 33% acetic acid. The biofilm formation index was calculated as the ratio of the absorbance of CV to the absorbance of the planktonic cells measured using MSS at A 600nm .
Determination of Minimum Biofilm Eradication Concentration
The Minimum Biofilm Eradication Concentration (MBEC) was determined by modifying the protocols described earlier (Parkins, Howard and Douglas 2001; Qu et al. 2010) . Biofilms were set in 24-well tissue culture plates with an inoculum size of 10 5 cells in cation-adjusted Mueller Hinton broth and incubated for 24 h at 37
• C. Growth in control wells and sterility control wells were employed to ascertain proper growth and to check for contamination, respectively. The spent media was discarded, and the wells were refilled with media containing 2-fold serial dilutions of antibiotics. The concentrations used were equal to and higher than the MIC values of the strain under test. The plate was incubated for a further 24 h at 37
• C. As before, the spent broth was discarded, and the wells were rinsed with sterile normal saline. The wells were once again refilled with antibiotic-free media and incubated for about 5-6 h at 37
• C. The viability of the biofilms was detected with the help of the redox dye triphenyltetrazolium chloride used at a final concentration of 0.05% (Klancnik et al. 2010) . This dye turns from pale yellow to pink in the presence of viable cells, and the color was measured using MSS at A 490nm . The antibiotic concentration corresponding to the well exhibiting no cell viability was considered the MBEC value, i.e. the concentration of antibiotic required to inhibit the biofilm.
Microscopic analysis
Biofilms of the cells expressing beta-lactamases were grown on sterile glass coupons in 24-well tissue culture plates. After incubation for 24 h at 37
• C, the coupons were carefully transferred to another 24-well plate containing sterile saline. The planktonic cells and excess media were gently washed. The biofilms on the coupons were stained with 0.01% CV and fixed on a slide. The biofilms were observed under the Olympus IX71 microscope fitted with a cooled CCD (charge coupled device) camera (Olympus Inc, Japan). The images were digitally captured using Cell-sens software (Olympus Inc). Similarly, for fluorescence microscopy, the biofilms formed on the coupons were stained with BacLight Live/Dead dye (Invitrogen Inc., CA, USA) in normal saline and viewed at ×100 magnification using the OLYMPUS IX71 fluorescence microscope (Olympus Inc.).
RESULTS AND DISCUSSION
AmpG permease maintains an intrinsic beta-lactam resistance
In enterobacterial strains, AmpG permease transports PG fragments that are channeled into the murein remodeling pathway. However, when the bacterial cell is under the attack of betalactam antibiotics, the structural integrity of the cell is compromised due to lack of cross-linked PG leading to cell lysis (Cho, Uehara and Bernhardt 2014) . The rate of PG remodeling is not as fast as the import of PG fragments that leads to the accumulation of PG fragments in the cytosol. In the cells other than E. coli, such fragments bind to the AmpR regulator and induce the expression of chromosomal AmpC beta-lactamase. However, E. coli lack AmpR leading to a low-level constitutive expression of AmpC beta-lactamase.
To check whether AmpG has any role in modulating the sensitivity of beta-lactam antibiotics, the beta-lactam sensitivities of the wild-type E. coli, its ampG mutant and the ampG mutant complemented with AmpG were ascertained by the standard microbroth dilution technique (Table 1) .With all the antibiotics tested, ampG deletion caused an increase in susceptibility (Table 1) . AmpG permease is responsible for transport of anhydro muropeptides generated by PG hydrolysis. Some of these are reused directly while some act as signals to induce expression of AmpC beta-lactamase (Monteiro et al. 2011) . Absence of AmpG permease blocks the transport of PG fragments into the cytoplasm and results in the release of free disaccharides into the growth medium (Garcia and Dillard 2008) . Under beta-lactam action, the ampG mutant is unable to recycle its broken PG, and its sensitivity is increased which is facilitated by the increased breakdown of PG in the presence of beta-lactams. Upon in trans expression of AmpG permease in the ampG mutant, further increase in the beta-lactam sensitivity was observed. Membrane proteins when ectopically expressed in elevated levels are known to be toxic to cells (Ames, Mimura and Shyamala 1990) . It could be that the overexpression of AmpG permease channels compromises the integrity of the cells by hampering the PG recycling pathway which might be a reason for its enhanced sensitivity.
Alteration in the vulnerability of the ampG mutant to betalactam antibiotics indicates its probable role in maintaining the intrinsic beta-lactam resistance of E. coli. It could be that this gene exerts its effect in place of its role in the PG recycling pathway. 
AmpG participates in serine beta-lactamase expression
AmpG is involved in the AmpC induction pathway. We aimed to ascertain whether AmpG also had a role in the expression or regulation of other serine beta-lactamases in E. coli. If this is true, the ampG gene could be used as a potential antibiotic target to counter the action of beta-lactamases produced by the beta-lactam resistant bacteria. To ascertain the effect of this permease on the expression of serine beta-lactamases in E. coli, we determined the beta-lactam sensitivities of ampG strain and its ectopically complemented strain harboring serine betalactamases of three different Ambler classes-A, C and D. Different beta-lactam agents were chosen as substrates for specific beta-lactamases. Overall, we report that the absence of AmpG permease lowers the beta-lactam resistance of E. coli. The resistance is further reduced in the presence of excess permease as noted in Table 1 . Upon expression of beta-lactamases, such as TEM-1, OXA-2 and AmpC, in the ampG mutant complemented with cloned AmpG, enhanced beta-lactam sensitivity as compared to the sensitivities of the ampG mutant harboring the respective beta-lactamases was observed (Table 2) .
AmpG transports about 45% peptides for remodeling PG (Liu et al. 2014) . Due to the deprivation of PG recycling intermediates, the absence of AmpG permease would lower the beta-lactam resistance. Research suggests that some residues are conserved in AmpG such as G29, A129 and A197, whose mutation prevents the binding of substrate to this transmembrane protein (Li et al. 2016) . Also, class A and D beta-lactamases are hypothesized to be related to low molecular mass PBPs. There is a possibility that these beta-lactamases may alter the substrates involved in PG recycling (Gallant et al. 2005) . Elevated levels of permease along with beta-lactamases probably pose a phenotypic cost to the bacteria by impairing the PG remodeling process, thereby compromising its structural integrity.
Alteration in beta-lactamase induction mediated by AmpG permease
To correlate the pronounced drop in beta-lactam resistance in the absence of ampG in E. coli, the inducibility of the betalactamases in the absence of ampG was ascertained by the nitrocefin hydrolysis assay. Expression of the AmpG permease lowered the beta-lactam resistance of strains expressing the beta-lactamases TEM-1, OXA-2 and AmpC. A similar outcome was attained in the nitrocefin hydrolysis assay by beta-lactamases expressed in the presence of excess AmpG permease. It is evident from the nitrocefin hydrolysis assay of the cell lysates that the expressions of all three beta-lactamases are reduced in the presence of ectopically expressed AmpG permease (Fig. 1a-c) .
Also, AmpG permease functions to import degraded PG fragments into the cytoplasm. The absence of this gene means that the PG recycling pathway would be blocked leading to an increase in the vulnerability of the cell to antibiotics that target the PG synthesis. Therefore, in the absence of ampG, the cells would be an easy target of beta-lactam antibiotics. Additionally, the accumulation of anhydromuropeptides is known to act as an inducing signal of AmpC beta-lactamase expression in inducible systems. The absence of AmpG permease would also mean no signal and lowered beta-lactamase expression.
Loss of ampG reduces biofilm formation
AmpG is a single component transporter protein (Cheng and Park 2002) . AmpG permease belongs to the major facilitator superfamily of transporters and is classified as a member of the peptide-acetyl-CoA (PAT) family and is fueled by proton motive force. To check whether AmpG has any role in biofilm formation, the effect of AmpG deletion and subsequent overexpression on biofilm formation were studied. Deletion of AmpG permease from E. coli 25113 resulted in a depressed biofilm formation to the tune of 73.5% as compared to the wildtype parent (Fig. S1, Supporting Information) . This implies a role of AmpG permease in biofilm formation. We hypothesize that the loss in the compactness of the bacterial cells leads to the minimization of E. coli biofilm formation.
Interestingly, upon expression of AmpG permease in trans in the ampG strain, there was a pronounced decrease in biofilm formation (approximately 33%) as compared to its deletion mutant (Fig. S1, Supporting Information) . Nevertheless, it is noteworthy to mention that the mutant strains harboring the empty pBAD18-Cam did not show any effect on biofilm formation (data not shown). Biofilm formation is a unique bacterial property which enables otherwise unicellular cells to form multicellular structures. This transition allows bacterial cells to evade the adverse effects induced by stressed conditions as well as to negate the impact of toxic substances and drugs. The AmpG permease serves to transport the fragments generated during murein turnover into the cytoplasm (Uehara and Park 2003) . Removal of this permease might adversely affect the uptake of anhydromuropeptides.
The ectopic expression of AmpG permease in the mutant further lowered biofilm formation which is quite an unexpected observation. The expression of AmpG permease in the ampG strain may hamper the cell viability within the biofilm. To assess this, biofilms were formed on coupons by both the mutant and its complemented strain. To further check the distribution of live and dead bacteria in the formed biofilms, these were visualized microscopically by labeling with BacLight Live/Dead stain (Fig. 2) . All the images pertain to the biofilms formed at the air-liquid interphase. Evidently, biofilms formed by the parent E. coli strain BW had a higher incidence of dead cells at the air-liquid interphase (Fig. 2d) . However, there was a marked reduction in the biofilm-forming ability of the ampG mutant as compared to the parent strain. Interestingly, biofilms formed after the ectopic expression of pKMG in the ampG strain displayed a more significant incidence of dead cells, like the result observed for the parent strain, though the reason for the appearance of cells killed in excess is unclear. Nevertheless, the overall result confirms our previous observation that ectopic expression of AmpG permease compromises the viability of the formed biofilms. Absence of AmpG permease impairs biofilm formation in the presence of beta-lactamases Biofilms enhance the antibiotic resistance of bacterial strains as compared to their planktonic counterparts. Changes in the susceptibility patterns of the beta-lactamase induced biofilms with respect to the presence or absence of AmpG permease were tested by determining their MBEC values (Table 3) . There was a reduction in the biofilm formation indexes of the ampG strains and the susceptibility of biofilms in the presence of the beta-lactamases that belong to Ambler class A and C. An increment in the susceptibility of beta-lactamase mediated biofilms was observed upon expression of the AmpG permease in trans. The presence of an increased number of transport channels results in many mislocalizations, poor folding efficiencies and enhanced toxicity to the cell that may explain their enhanced susceptibility to beta-lactams (Ames, Mimura and Shyamala 1990) . However, OXA-2 was an exception as its presence increased the resistance of the biofilms upon AmpG expression for hitherto unknown reasons.
From the above results, we observe that biofilms are affected by the absence of the AmpG permease. So, we may infer that AmpG plays a crucial role in biofilm formation both in presence and absence of serine beta-lactamases, thereby denoting it to be a likely antibiotic target.
SUMMARY AND CONCLUSION
AmpG permease has a noticeable effect on beta-lactamase expression. Its absence lowers beta-lactam susceptibility by many folds. We hypothesize that this permease is critical to the entry of degraded PG fragments and could serve as a lethal target of antibiotics when used in conjunction with a beta-lactam. The most striking fact elucidated from our results is the outlining of the requirement of AmpG permease for biofilm formation. Overall, it may be inferred that AmpG permease plays a sentinel role in biofilm formation and its absence drastically reduces biofilm formation irrespective of the presence of biofilm enhancing beta-lactamases such as AmpC enzymes. Therefore, AmpG permease may be considered as a therapeutic target for reducing antibiotic resistance mediated by beta-lactamase expression as well as by beta-lactamase facilitated biofilm formation.
In a nutshell, designing of an AmpG inhibitor in future may provide dual protection against antibiotic resistance by sensitizing the cells possibly through the promotion of entry of the betalactam antibiotic in both planktonic and sessile populations of cells.
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